Walden Biosciences

📍 Cambridge, United States🗓 Founded 2020👥 23 employees💰 Last funded Aug 2024
Biotechnology Research🌐 waldenbiosciences.com
Website LinkedIn
Walden Biosciences is a biotechnology company relentlessly focused on developing first-in-class, highly-targeted therapies for individuals living with kidney disease. We are developing breakthrough medicines targeted directly to the kidney and will be successful through our comprehensive knowledge and understanding of novel kidney-specific biological pathways and our team’s track record in drug discovery. Our goal is to transform the treatment of kidney disease by reversing its progression, enabling and inspiring patients to resume their normal lives. Our culture is collaborative and entrepreneurial, and our team is dynamic and driven by data and innovation. We want to make the best decisions with the best available information, lead by example, and bring transformative medicines to patients in need. Walden is based in the heart of Cambridge, MA between Harvard, Massachusetts Institute of Technology (MIT), and Massachusetts General Hospital.
3
Total investors
1
Early stage
2
Mid stage
0
Late stage
2020
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
Belgium
1
Investor activity2019–2024 · investors recorded per year
201912023120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Walden Biosciences?
Walden Biosciences has 3 investors on record on gritt.io, including 1 early-stage backers, 2 mid-stage.
When did Walden Biosciences last raise funding?
The most recent investment in Walden Biosciences recorded on gritt.io was in August 2024.
When was Walden Biosciences founded?
Walden Biosciences was founded in 2020.
What industry is Walden Biosciences in?
Walden Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Walden Biosciences based?
Walden Biosciences is headquartered in Cambridge, United States.